DiaSorin S.p.A.
DIA
Rank in Stocks
#3801
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Share Price
$88.31
Last synced: 2026-10-21
Market Cap
$4.37B
Change (1 day)
-6.35%
Change (1 year)
-2.42%
Country
IT
Trade DiaSorin S.p.A. (DIA)
Category
Healthcare
Stock split history for DiaSorin S.p.A. (DIA)
DiaSorin S.p.A. stock (symbol: DIA) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 22, 2026.
One DIA share bought prior to Oct 22, 2026 would equal to 0 DIA shares today.
The most recent stock split occurred on Oct 22, 2026.
One DIA share bought prior to Oct 22, 2026 would equal to 0 DIA shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
